Is Ozone Therapy Safe? Risks, Benefits and the Evidence (2026)

Ozone therapy occupies an unusual position in modern medicine. It is widely offered, increasingly popular in wellness and longevity circles, and practised by thousands of clinicians worldwide, yet it has not been approved by major regulatory bodies and the evidence base remains thinner than many patients realise. If you are searching for a straightforward answer to whether ozone therapy is safe, the honest response is that it depends heavily on how it is administered, by whom, and for what purpose.

When delivered by a trained medical practitioner using established protocols, ozone therapy is generally tolerated without serious incident by most patients. However, that is not the same as saying it is proven safe. The US Food and Drug Administration issued a clear warning in 2019 stating that there is insufficient evidence of ozone therapy's safety and effectiveness, and it has not authorised or regulated the therapy for any medical condition. The distinction between "commonly tolerated" and "proven safe" matters a great deal in healthcare, and it is one that anyone considering ozone therapy should understand before proceeding.

This article is specifically about the safety question. If you are looking for a broader overview of what ozone therapy is, how it works and where to find it in Ireland, our separate guide to ozone therapy in Ireland covers that ground. Here, the focus is squarely on what can go wrong, what the evidence says about risk, and how to protect yourself if you decide to go ahead. This is not medical advice, and nothing in this article should replace a conversation with your own doctor.

The FDA's position on ozone therapy is unambiguous and has been consistent for years. In its 2019 advisory, the agency stated that ozone is a toxic gas with no known useful medical application, and that exposure to high levels of ozone gas may worsen chronic respiratory diseases such as asthma and compromise the body's ability to fight respiratory infections. The FDA has not authorised ozone therapy for the treatment, prevention or cure of any disease, and it has taken enforcement action against companies making therapeutic claims about ozone generators.

It is worth understanding what this does and does not mean. The FDA regulates medical devices and drugs in the United States, and its lack of approval reflects an assessment that the submitted evidence has not met the agency's threshold. It does not mean the therapy has been proven dangerous in every context, nor does it mean that the thousands of practitioners using it worldwide are all acting recklessly. What it does mean is that, by the standards of the world's most influential drug regulator, the case for ozone therapy has not been made.

In Europe, the picture is more fragmented. Some countries, notably Germany, Italy and Spain, have a longer tradition of clinical ozone use and somewhat more permissive regulatory environments. In Ireland, there is no specific regulatory framework for ozone therapy. The Health Products Regulatory Authority regulates medicines and medical devices, but ozone therapy falls into a grey area that is neither explicitly permitted nor prohibited. The Medical Council of Ireland has not officially endorsed the therapy. This regulatory ambiguity means that the burden of due diligence falls largely on the patient, making it all the more important to understand the risks before committing.

The most comprehensive assessment of ozone therapy safety available is a 2026 umbrella review published in the journal Medical Sciences, which synthesised findings from multiple systematic reviews and meta-analyses of randomised controlled trials. This kind of study sits at the top of the evidence hierarchy because it draws together the broadest possible view of what research has found. The review's conclusion was measured: while some applications showed therapeutic promise, the overall quality of evidence was low and the volume of large-scale human trials remained limited.

A 2024 comprehensive review published in the European Journal of Medical Research focused specifically on musculoskeletal applications, an area where ozone therapy has attracted particular clinical interest for conditions like herniated discs and osteoarthritis. This review found some encouraging results in terms of pain reduction, but again noted that the evidence base needed strengthening with larger, better-designed trials before firm conclusions about safety and efficacy could be drawn.

The Cleveland Clinic, one of the most respected medical centres in the United States, has described the evidence for ozone therapy as "low-quality and limited." This assessment is echoed across mainstream medicine. The therapy has simply not been tested in the kinds of large-scale, rigorous human clinical trials that would be required to establish a confident safety profile for most of the conditions it is marketed for. This does not prove it is dangerous, but it does mean that patients are operating with incomplete information about risk, which is a relevant consideration for anyone making a healthcare decision.

The side effects of ozone therapy vary considerably depending on the method of administration. Rectal insufflation, one of the most common delivery methods, can cause discomfort, cramping, and a feeling of pressure in the abdomen. These effects are generally mild and temporary, but they can be unpleasant, particularly during the first few sessions. Some patients also experience what is known as a Herxheimer reaction, a cluster of flu-like symptoms including fatigue, headache, mild fever and muscle aches that practitioners attribute to the body's response to the release of toxins or dying pathogens. While typically short-lived, these reactions can be disconcerting for patients who are not expecting them.

Respiratory symptoms are among the more concerning side effects. Exposure to ozone gas, even at concentrations used therapeutically, can cause burning eyes, coughing, nausea and headaches. These are well-documented effects of ozone exposure in both occupational and environmental health literature. The respiratory system is particularly vulnerable because ozone is a powerful oxidant that reacts with the lining of the airways, and even brief inhalation at elevated concentrations can trigger inflammation.

It is critical to understand that ozone should never be inhaled directly. This is one of the few absolute rules in ozone therapy on which virtually all practitioners agree. Any delivery method that risks the patient breathing in ozone gas, whether through poor technique, equipment failure or simple carelessness, introduces a genuinely dangerous exposure. The fact that ozone has known respiratory toxicity at atmospheric concentrations well within the range used in therapeutic settings is precisely why proper equipment, training and clinical protocols are non-negotiable.

Beyond the common side effects, ozone therapy carries a small number of genuinely serious risks that anyone considering the treatment must understand. The most alarming is the risk of air embolism during intravenous administration. An air embolism occurs when a bubble of gas enters the bloodstream and travels to the heart, lungs or brain, where it can block blood flow. The consequences can be catastrophic, including stroke, heart attack and, in rare cases, death. This risk is specific to methods that involve injecting ozone directly into the vein, and it is the primary reason why many mainstream medical bodies regard intravenous ozone with particular caution.

Acute lung injury is another serious risk associated with ozone therapy, and it can occur when ozone is inadvertently inhaled during treatment. The lungs have limited antioxidant defences against a gas as reactive as ozone, and acute exposure can cause inflammation, fluid accumulation and significant respiratory distress. Repeated or chronic inhalation exposure carries the further risk of contributing to the development or worsening of conditions such as asthma and chronic obstructive pulmonary disease. These are not theoretical concerns but established consequences of ozone exposure documented extensively in environmental health research.

The seriousness of these risks does not mean they occur frequently. In the hands of an experienced, properly trained practitioner using well-maintained equipment and appropriate protocols, serious adverse events appear to be uncommon. But "uncommon" is not "impossible," and the consequences when they do occur can be life-altering. This is exactly why the qualifications and experience of the person administering the therapy matter so much, and why the regulatory vacuum around ozone therapy is a genuine concern rather than a bureaucratic technicality.

There are several groups of people for whom ozone therapy is considered clearly contraindicated, meaning the risks are judged to outweigh any possible benefit regardless of the delivery method. Pregnancy is an absolute contraindication, as the effects of ozone exposure on foetal development have not been established and the precautionary principle applies. People with hyperthyroidism should avoid ozone therapy because the therapy can stimulate metabolic activity in ways that may worsen an already overactive thyroid. Those with glucose-6-phosphate dehydrogenase deficiency, known as G6PD deficiency, face a specific biochemical risk because their red blood cells lack adequate protection against the oxidative stress that ozone deliberately creates.

Active bleeding disorders and severe cardiovascular disease are also contraindications. In the case of bleeding disorders, the concern is that ozone's effects on blood chemistry could interfere with clotting. For patients with severe heart or vascular disease, the circulatory stress and the small but real risk of embolism make the treatment inadvisable without very careful specialist assessment. These contraindications are not a matter of debate among practitioners and represent a baseline safety standard that any responsible clinic should screen for before treatment begins.

Beyond these absolute contraindications, there are a number of relative cautions. People taking blood-thinning medication, those with a history of seizures, and anyone with compromised immune function should discuss ozone therapy thoroughly with their doctor before proceeding. A responsible practitioner will take a full medical history, ask about current medications, and decline to treat patients for whom the risk profile is unfavourable. If a clinic does not ask detailed questions about your health before agreeing to treat you, that itself is a red flag about the standard of care you can expect.

In Ireland, ozone therapy exists in something of a regulatory grey area. The Health Products Regulatory Authority oversees medicines and medical devices, but ozone therapy does not fall neatly into either category. The Medical Council of Ireland, which regulates doctors, has not issued specific guidance endorsing or prohibiting the practice. The result is that ozone therapy is neither officially sanctioned nor explicitly banned, and its availability depends on individual practitioners choosing to offer it within their clinical practice.

The practitioners offering ozone therapy in Ireland are typically qualified doctors or integrative medicine practitioners. Clinics such as Drummartin Clinic in Dublin, Integrative Medicine Dublin, Regenecare, East Clinic and Karuna Flame are among those currently providing the treatment. The Irish Medical Ozone Association also exists as a professional body. Costs vary significantly depending on the type of treatment: an initial consultation at Drummartin Clinic is around €250, high-dose ozone therapy ranges from €420 to €730, and prolozone injections for joints cost between €130 and €375 depending on the joint being treated.

When choosing a practitioner in Ireland, there are several things you should look for to protect yourself. The treating practitioner should be a registered medical doctor or have equivalent clinical qualifications. They should conduct a thorough medical history and screening before any treatment, explain the specific risks relevant to your chosen method of administration, and be transparent about what the evidence does and does not support. They should use properly maintained, medical-grade ozone generators and follow established dosing protocols. Be cautious of any practitioner who guarantees results, dismisses the risks, or discourages you from consulting your GP. The absence of strong regulatory oversight in this area means you need to be your own advocate.

If you have weighed the evidence and decided you want to explore ozone therapy, going into your first consultation well prepared can make a significant difference to your safety. Start by asking about the practitioner's qualifications and training specifically in ozone therapy. A medical degree is a starting point, but ozone therapy requires additional specialist knowledge in dosing, equipment and recognising adverse reactions. Ask where they trained in ozone therapy, how long they have been practising it, and how many patients they have treated.

Ask about the specific method of administration being recommended for your situation and why that method has been chosen over alternatives. Different delivery routes carry different risk profiles, and a good practitioner will be able to explain the reasoning behind their recommendation in terms you understand. Ask what side effects you should expect and what serious complications are possible, however rare. Ask about their emergency protocols and what happens if something goes wrong during treatment. A practitioner who is uncomfortable with these questions, or who minimises the risks, is not someone you should trust with your care.

Finally, ask what outcomes you can realistically expect and over what timeframe. Be particularly alert to claims that ozone therapy can cure cancer, reverse autoimmune disease, or treat conditions for which it has no established evidence base. Responsible practitioners will be honest about the limitations of the evidence and will frame ozone therapy as one component of a broader health strategy rather than a standalone cure. If the conversation feels more like a sales pitch than a clinical consultation, trust that instinct and seek a second opinion.

Ozone therapy is not as straightforwardly dangerous as its harshest critics suggest, nor is it as thoroughly proven safe as its most enthusiastic advocates claim. The reality sits somewhere in between. When administered by a qualified practitioner following established protocols, serious adverse events appear to be uncommon, and many patients undergo treatment without significant problems. But the evidence base remains limited, the regulatory framework is patchy, and the serious risks that do exist, particularly air embolism and respiratory injury, are severe enough to warrant genuine caution.

The most important thing you can do to protect yourself is to make an informed decision. That means understanding the FDA's position and why it matters, knowing the specific risks associated with your chosen method of administration, being honest with your practitioner about your medical history, and having realistic expectations about what the therapy can and cannot deliver. It also means choosing your practitioner carefully, favouring those with proper medical training, transparent practices and a willingness to discuss the limitations of the evidence.

This article is intended to help you ask better questions and make a more informed choice, but it is not a substitute for professional medical advice. If you are considering ozone therapy, particularly for a specific health condition, speak to your GP or specialist first. They can help you weigh the potential benefits against the known risks in the context of your individual health situation. Whatever you decide, go in with your eyes open, because in a field where the regulation is thin and the marketing can be thick, your own due diligence is your best protection.